Trial intelligence / Profile preview

Emla cream vs lavender oil vs cold compress for injection pain in cardiac patients on enoxaparin

IRCT20100829004655N9Phase 2Completed

Sponsor
Kashan University of Medical Sciences
Start
Apr 2018
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of prilocaine, lavender oil and enoxaparin (3 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Injection site pain intensity and Patient comfort. Started Apr 2018; status: completed.

02

Drugs

prilocainelavender oilenoxaparin

Beyond the preview

Go deeper on IRCT20100829004655N9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100829004655N9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call